Lamotrigine Ratiopharm®

Lamotrigine, the active ingredient in Lamotrigine Ratiopharm®, is a sodium channel blocker presented as an oral tablet for oral use. It is employed to control partial seizures, generalized tonic‑clonic seizures and to maintain mood stability in bipolar disorder.

GNH USA supplies Lamotrigine Ratiopharm® as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory documentation for import and distribution. Our global logistics network ensures timely delivery to diverse healthcare settings.

Lamotrigine is used to treat seizure disorders and bipolar disorder by modulating neuronal excitability.

- Partial seizures: reduces frequency and severity of focal onset seizures in patients with epilepsy. - Generalised tonic‑clonic seizures: helps prevent convulsive seizures and improves seizure control in generalized epilepsy. - Bipolar disorder (maintenance therapy): stabilises mood, decreasing the risk of depressive and manic relapses in bipolar patients.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as agranulocytosis - Severe hepatic injury - Suicidal thoughts or behavior

When prescribing lamotrigine, clinicians should observe several precautionary measures to minimise risk.

- Dose titration: increase gradually to reduce the incidence of skin reactions. - Pregnancy: safety data are limited; discuss potential risks with the prescriber. - Renal impairment: assess kidney function and adjust dosage if necessary. - Valproate co‑therapy: may raise lamotrigine levels, requiring closer monitoring. - Store at ambient temperature: keep in the original container, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase adverse effect risk.

Major Interactions (Avoid): - Valproic acid: can markedly increase lamotrigine concentrations, raising toxicity risk. - Carbamazepine: induces metabolism and may lower lamotrigine levels, reducing efficacy. - Phenobarbital: accelerates lamotrigine clearance, potentially leading to treatment failure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, possibly requiring dose adjustment. - Rifampin: enhances hepatic enzymes and can lower lamotrigine concentrations. - Serotonergic agents: combined use may increase risk of serotonin syndrome; monitor patient.